Clinical Trials
2 trialsNCT00425035 2013-05-13
Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2
Amgen
Phase 2 Completed
NCT00004879 2013-01-08
Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer
Jonsson Comprehensive Cancer Center
Phase 1 Completed